miguel.segura@vhir.org
SEGURA GINARD, MIGUEL
iMarina ID: 04-1007Grup
Recerca translacional amb càncer infantil. Vall d'Hebron Institut de Recerca (VHIR). Passeig de la Vall d'Hebron. Barcelona. 08035
Servei
Oncologia. Hospital Universitari Vall d'Hebron. Passeig de la Vall d'Hebron. Barcelona. 08035
Codis d'identificació
Cronologia
maig de 2006
Doctorat: Molecular Biology
Universitat de Lleida
juny de 2000
Titulat superior / Grau: Bachelor of Science. Biochemistry
Universitat de les Illes Balears (UIB)
Cronologia
gener de 2017
Investigador principal
Vall d'Hebron Institut de Recerca (VHIR). Recerca translacional amb càncer infantil
2017 -
gener de 2017
Investigador principal
Hospital Universitari Vall d'Hebron. Oncologia
2017 -
juny de 2011
Sénior
Vall d'Hebron Institut de Recerca (VHIR). Recerca translacional amb càncer infantil
2011 -
juny de 2011
Sénior
Hospital Universitari Vall d'Hebron. Oncologia
2011 -
gener de 2007
Postdoctoral Researcher at New York University School of Medicine
New York University School of Medicine
2007 - 2012
gener de 2006
Postdoctoral Researcher at Hospital Arnau de Vilanova (Lleida)
Hospital Universitari Arnau de Vilanova
2006 - 2007
gener de 2000
University of Lleida. Graduate Student
Universitat de Lleida (UdL)
2000 - 2006
gener de 1998
University of Illes Baleas. Undergraduate Student
Universitat de les Illes Balears (UIB)
1998 - 2000
Reconeixements Investigació
Reconeixements Docents
Temàtiques més freqüents
Temáticas
Projectes participats
Direcció y participació en projectes
IP
NO IP
Grups, xarxes
Activitat docent
Tesi Dirigides
2
Centres
Universitat Autònoma de Barcelona
Universitat de Lleida
Assignatura/Curs
Publicacions en Altmetrics
| 2019 | MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and ... | |
| 2019 | Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new t... | |
| 2019 | Interplay between ncRNAs and cellular communication: A proposal for understandin... | |
| 2019 | A High-Throughput Screening Identifies MicroRNAInhibitors That Influence Neurona... | |
| 2018 | Targeting of epigenetic regulators in neuroblastoma. | |
| 2018 | Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal canc... | |
| 2017 | miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemnes... | |
| 2017 | Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic ... | |
| 2017 | Hedgehog Pathway Inhibition Hampers Sphere and Holoclone Formation in Rhabdomyos... | |
| 2017 | Krüppel-like factor 4 (KLF4) regulates the miR-183~96~182 cluster under physiolo... | |
| 2017 | Patient-derived xenografts for childhood solid tumors: a valuable tool to test n... | |
| 2017 | Combined miRNA profiling and proteomics demonstrates that different miRNAs targe... | |
| 2017 | MicroRNA-200, associated with metastatic breast cancer, promotes traits of mamma... | |
| 2016 | [Novel micro RNA-based therapies for the treatment of neuroblastoma]. | |
| 2016 | MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal tra... | |
| 2016 | BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of... | |
| 2016 | MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeti... | |
| 2016 | Fas apoptosis inhibitory molecules: More than death-receptor antagonists in the ... | |
| 2016 | SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregu... | |
| 2015 | Modulation of chemotherapeutic drug resistance in neuroblastoma SK-N-AS cells by... | |
| 2015 | Identification of metastasis-suppressive microRNAs in primary melanoma. | |
| 2015 | Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant... | |
| 2015 | TNF alpha sensitizes neuroblastoma cells to FasL-, cisplatin- and etoposide-indu... | |
| 2014 | MYCN repression of Lifeguard/FAIM2 enhances neuroblastoma aggressiveness. | |
| 2014 | Optimization of rhabdomyosarcoma disseminated disease assessment by flow cytomet... | |
| 2014 | MiRNA-targeted therapies in the most prevalent pediatric solid tumors | |
| 2013 | FAIM-L is an IAP-binding protein that inhibits XIAP ubiquitinylation and protect... | |
| 2013 | Hedgehog pathway blockade inhibits melanoma cell growth in vitro and in vivo. | |
| 2013 | Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch sign... | |
| 2013 | BRD4 sustains melanoma proliferation and represents a new target for epigenetic ... | |
| 2013 | microRNAs as pharmacological targets in cancer | |
| 2013 | BRD4 is a new therapeutic target in melanoma | |
| 2012 | MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy. | |
| 2012 | MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma. | |
| 2012 | MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, an... | |
| 2012 | Histology-specific microRNA alterations in melanoma. | |
| 2011 | The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating poten... | |
| 2011 | miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppre... | |
| 2011 | Efficient in vivo microRNA targeting of liver metastasis. | |
| 2010 | The histone variant macroH2A suppresses melanoma progression through regulation ... | |
| 2010 | Melanoma MicroRNA signature predicts post-recurrence survival. | |
| 2009 | Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and... | |
| 2007 | Lifeguard/neuronal membrane protein 35 regulates Fas ligand-mediated apoptosis i... | |
| 2007 | Reelin induces the detachment of postnatal subventricular zone cells and the exp... | |
| 2007 | Reactive oxygen species and p38 mitogen-activated protein kinase activate Bax to... | |
| 2007 | The long form of Fas apoptotic inhibitory molecule is expressed specifically in ... | |
| 2004 | Characterization of splice variants of human caspase-activated DNase with CIDE-N... | |
| 2004 | The death receptor antagonist FAIM promotes neurite outgrowth by a mechanism tha... | |
| 2003 | Mu-opioid receptor activation prevents apoptosis following serum withdrawal in d... |
Col·laboracions institucionals darrers 5 anys
